NASHVILLE, Tenn. / Aug 30, 2023 / Business Wire / HCA Healthcare, Inc. (NYSE:HCA), is scheduled to present at the following healthcare conference:
September 12, 2023 at 9:30 am EDT at the Morgan Stanley 21st Annual Global Healthcare Conference held at the Sheraton New York in New York, NY.
A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company’s website, www.hcahealthcare.com.
Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company’s website for the latest information.
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 182 hospitals and approximately 2,300 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom.
All references to “Company” and “HCA” as used throughout this release refer to HCA Healthcare, Inc. and its affiliates.
| Last Trade: | US$387.98 |
| Daily Change: | -9.77 -2.46 |
| Daily Volume: | 1,802,296 |
| Market Cap: | US$100.130B |
July 23, 2024 April 26, 2024 April 03, 2024 | |
Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address...
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
